Low molecular weight heparin and cancer survival: clinical trials and experimental mechanisms

被引：0
|
作者：
Ning Zhang
Weihua Lou
Fang Ji
Lihua Qiu
Benjamin K. Tsang
Wen Di
机构：
[1] Shanghai JiaoTong University,Department of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine
[2] Shanghai Key Laboratory of Gynecologic Oncology,Macau Institute for Applied Research in Medicine and Health3, State Key laboratory of Quality Research in Chinese Medicine
[3] Macau University of Science and Technology,Department of Obstetrics & Gynecology and Cellular & Molecular Medicine, Interdisciplinary School of Health Sciences, University of Ottawa, and Chronic Diseases Program
[4] Ottawa Hospital Research Institute,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2016年 / 142卷
关键词：
Cancer; Low molecular weight heparin; Survival; Randomized trial; Molecular mechanisms;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1807 / 1816
页数：9
相关论文
共 50 条
  • [41] CLINICAL AND EXPERIMENTAL STUDIES ON AN ULTRA-LOW MOLECULAR-WEIGHT HEPARIN (CY-222)
    TOULEMONDE, F
    PLATET, JP
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1109 - 1109
  • [42] Low molecular weight heparin (LMWH) versus best supportive care in cancer patients.: A meta-analysis of randomized clinical trials
    Laporte, S.
    Meyer, G.
    Bueller, H. R.
    Decousus, H.
    Moulin, N.
    Cucherat, M.
    Mismetti, P.
    THROMBOSIS RESEARCH, 2007, 120 : S164 - S164
  • [43] Toward a disparition of antitumoral effect of low molecular weight heparin (LMWH) in cancer patients since the first trials
    Ollier, E.
    Chapelle, C.
    Trone, J. C.
    Bertoletti, L.
    Girard, P.
    Meyer, G.
    Cucherat, M.
    Mismetti, P.
    Laporte, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 13 - 13
  • [44] HEPARIN, LOW-MOLECULAR WEIGHT HEPARIN, AND HEPARIN ANALOGS
    THOMAS, DP
    BRITISH JOURNAL OF HAEMATOLOGY, 1984, 58 (03) : 385 - 390
  • [45] Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer
    Akl, Elie A.
    Labedi, Nawman
    Terrenato, Irene
    Barba, Maddalena
    Sperati, Francesca
    Sempos, Elena V.
    Muti, Paola
    Cook, Deborah
    Schuenemann, Holger
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (11):
  • [46] Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer
    Akl, Elie A.
    Kahale, Lara
    Sperati, Francesca
    Neumann, Ignacio
    Labedi, Nawman
    Terrenato, Irene
    Barba, Maddalena
    Sempos, Elena V.
    Muti, Paola
    Cook, Deborah
    Schuenemann, Holger
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (06):
  • [47] Low-molecular-weight heparin and the survival of patients with advanced malignancy.
    Klerk, CPW
    Smorenburg, S
    Otten, HM
    Richel, D
    Van Tienhoven, G
    Lensing, A
    Büller, H
    Prandoni, P
    Bos, M
    Prins, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 733S - 733S
  • [48] Prolongation of rat skin and cardiac allograft survival by low molecular weight heparin
    Shapira, OM
    Rene, H
    Lider, O
    Pfeffermann, RA
    Shemin, RJ
    Cohen, IR
    JOURNAL OF SURGICAL RESEARCH, 1999, 85 (01) : 83 - 87
  • [49] Heparin and low-molecular-weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats
    Dotan, I
    Hershkoviz, R
    Karmeli, F
    Brazowski, E
    Peled, Y
    Rachmilewitz, D
    Halpern, Z
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (10) : 1687 - 1697
  • [50] EXPERIMENTAL VENOUS THROMBOSIS IN RATS TREATED WITH HEPARIN AND A LOW-MOLECULAR WEIGHT HEPARIN FRACTION
    DOUTREMEPUICH, C
    GESTREAU, JL
    MAURY, MO
    QUILICHINI, R
    BOISSEAU, MR
    TOULEMONDE, F
    VAIREL, E
    HAEMOSTASIS, 1983, 13 (02) : 109 - 112
12345